3,4-dihydro-2H-pyran-4-one → 4-(2-(2-Ethyl-1h-benzo[d]imidazol-1-yl)-9-methyl-8-((1-(tetrahydro-2h-pyran-4-yl)azetidin-3-yl)methyl)-9h-purin-6-yl)morpholine

HRID 1923192Notes

Reaction equation

HRID 1923192 reaction equation
[O:1]1[CH:6]=[CH:5][C:4](=O)[CH2:3][CH2:2]1.[NH:8]1[CH2:11][CH:10]([CH2:12][C:13]2[N:14]([CH3:39])[C:15]3[C:20]([N:21]=2)=[C:19]([N:22]2[CH2:27][CH2:26][O:25][CH2:24][CH2:23]2)[N:18]=[C:17]([N:28]2[C:32]4[CH:33]=[CH:34][CH:35]=[CH:36][C:31]=4[N:30]=[C:29]2[CH2:37][CH3:38])[N:16]=3)[CH2:9]1>>[CH2:37]([C:29]1[N:28]([C:17]2[N:16]=[C:15]3[C:20]([N:21]=[C:13]([CH2:12][CH:10]4[CH2:11][N:8]([CH:4]5[CH2:5][CH2:6][O:1][CH2:2][CH2:3]5)[CH2:9]4)[N:14]3[CH3:39])=[C:19]([N:22]3[CH2:23][CH2:24][O:25][CH2:26][CH2:27]3)[N:18]=2)[C:32]2[CH:33]=[CH:34][CH:35]=[CH:36][C:31]=2[N:30]=1)[CH3:38]

Participants

3

Reactant 2

HCID 5667353,4-dihydro-2H-pyran-4-oneHCID 596052818-Azetidin-3-ylmethyl-2-(2-ethylbenzoimidazol-1-yl)-9-methyl-6-morpholin-4-yl-9H-purine

Product 1

HCID 498329424-(2-(2-Ethyl-1h-benzo[d]imidazol-1-yl)-9-methyl-8-((1-(tetrahydro-2h-pyran-4-yl)azetidin-3-yl)methyl)-9h-purin-6-yl)morpholine

Procedure

Following General Procedure L, 2H-pyran-4(3H)-one underwent reductive amination with 4-(8-(azetidin-3-ylmethyl)-2-(2-ethyl-1H-benzo[d]imidazol-1-yl)-9-methyl-9H-purin-6-yl)morpholine to give 503. 517.3 (MH+)

Sources & evidence

ORD record
ord-3d9aa69785664856b7d7b22499c436de
Source dataset
uspto-grants-2012_05
Patent number
US08173650B2

Reaction notes

Loading…